Methimez 5mg 30 Tablets

Babies: Not applicable. Lactating mothers: Methimez tablet is considered safe to use during breastfeeding.
Human studies state that the drug does not pass into breast milk and is not harmful to the baby. Pregnancy: Methimez tablet is considered unsafe to use during pregnancy.
There is definite evidence of risk to the developing baby. Please consult your doctor.
Driving: It is unsafe to drive while taking this medication. It may decrease alertness, affect your vision or make you feel sleepy and dizzy.
Do not drive if these symptoms occur. Alcohol: No information is available on whether it is safe to consume alcohol with this tablet.
Please consult your doctor. Liver: Methimez tablets should be used with caution in patients with liver disease.
Dose adjustment of this medication is required in patients. Please consult your doctor.
Regular monitoring of liver function tests is recommended while on this medication. Kidney: Methimez tablet is considered safe to use in patients with kidney disease.
Limited data available state that the dose adjustment of this medication is not required in patients. Please consult your doctor..

Skin rash Nausea Hair loss Headache Paresthesia (tingling or pricking sensation) Joint pain Taste change Drowsiness Muscle pain.

Methimez tablet is an anti-thyroid medication. It works by blocking the excessive production of thyroid hormones from the thyroid gland, thereby preventing hyperthyroidism symptoms..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Methimez tablet is used to treat hyperthyroidism • Discontinue this medication if you are also taking radio-iodine as a treatment for your overactive thyroid • Methimez tablets may influence the level of blood cells in your blood. Inform your doctor if you experience symptoms such as unexplained bruising or bleeding, sore throat, mouth ulcers, fever, or general illness • Quit the medication and inform your doctor if you develop symptoms of liver damage such as abdominal pain, loss of appetite, darkened urine, or yellowing of the eyes or skin • Inform your doctor if you are pregnant, intend to be pregnant, or breastfeeding.

Contraindicated • Methimez + Eliglustat: Methimez increases levels of eliglustat by affecting hepatic enzyme cyp2d6 metabolism • Methimez + Sodium iodide I-131: Methimez will decrease the level or effect of sodium iodide I-131 Serious • Methimez + Carbamazepine: Concurrent use of these drugs either increases toxicity of the other by pharmacodynamic synergism • Methimez + Clozapine: Concurrent use of these drugs either increases toxicity of the other by pharmacodynamic synergism • Methimez + Lonafarnib: Methimez will increase the level or effect of lonafarnib by affecting hepatic/ intestinal enzyme cyp3a4 metabolism • Methimez + Propylthiouracil: Concurrent use of these drugs either increases toxicity of the other by pharmacodynamic synergism Monitor closely • Methimez + Antithrombin iii: Methimez decreases effects of antithrombin iii by pharmacodynamic antagonism • Methimez + Heparin: Methimez decreases effects of heparin by pharmacodynamic antagonism.